4 Medical Reasons Why Precise Weighing Scales Should be Used
In the field of medicine, accuracy and precision play a crucial role. Whether it’s for patient care, medication dosing, nutritional management, or research purposes, using
August 8, 2023
The medical device space is growing rapidly as new startups and investments from major players enter the market. Some of the most notable investors in medical devices include venture capital firms such as Kleiner Perkins Caufield & Byers, Sequoia Capital, and Accel Partners, as well as large companies such as Johnson & Johnson and Medtronic.
This influx of investment is driving innovation in the medical device space, with new devices and treatments being developed all the time. This growth is also creating opportunities for entrepreneurs, who can now launch their own medical device startups and access funding from major players.
In the field of medicine, accuracy and precision play a crucial role. Whether it’s for patient care, medication dosing, nutritional management, or research purposes, using
The companies intend to deliver a novel approach to promote bone and tissue growth using Theradaptive’s unique protein-based material-binding variants to coat 3D Systems’ 3D-printed medical devices. This solution has the potential to provide patients with an opportunity for improved healing and thus better outcomes.
According to the Centers for Disease Control and Prevention (CDC), failure to wash hands regularly contributes to the spread of infections affecting 1 in 31 hospital patients each day. With this monitoring system, HAIs are expected to decrease by 83%.
The TRIA polymer surical mitral heart valve is designed specifically to accommodate the anatomy and pressures of the mitral position. It combines the company’s proprietary polymer – LifePolymer™ – with an innovative valve design intended to resist calcification, withstand stresses and strains without failure, and restore patient quality of life without lifelong use of anticoagulants.
“We are pleased to have safely implanted the first patient in China with the TaurusTrio™ TAVR System,” said Dr. Yi Zhang, Chief Executive Officer of Peija Medical. “The trial reinforces our goals of improving care in the field of cardiology and expanding TAVR systems within China. We are looking forward to our continued partnership with American company, JenaValve and presenting further data from the clinical trial at a future date.”
Dr. Matthieu Jeanne, Ph.D., Chief of Anesthesia and Intensive Care, Burn Treatment Center, principal investigator of the prospective randomized clinical validation study said, “This world first is an important step forward for the practice of anesthesia in general. This closed loop is the best companion for the surgeon, the anesthetist, and the patient since all three can be assured that the operation will be carried out in the best conditions of patient comfort and pain control”.